Chat with us
Research Assistance
Online
  • Please enter your first name.

Europe Interventional Cardiology Devices Market Size & Outlook

The interventional cardiology devices market in Europe is expected to reach a projected revenue of US$ 5,318.0 million by 2033. A compound annual growth rate of 7.4% is expected of Europe interventional cardiology devices market from 2026 to 2033.

  • MedTech
    • Cardiovascular Devices
      • Interventional Cardiology Devices Market Outlook
Revenue, 2025 (US$M)
$3,013.9
Estimate, 2026 (US$M)
$3,224.6
Forecast, 2033 (US$M)
$5,318.0
CAGR, 2026 - 2033
7.4%
Europe Interventional Cardiology Devices Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Global Market

Related Markets

Prism AI by Grand View ResearchFree to try

Ask a question about the interventional cardiology devices market

Every figure cited from GVR research

Europe interventional cardiology devices market highlights

  • The Europe interventional cardiology devices market generated a revenue of USD 3,013.9 million in 2025.
  • The market is expected to grow at a CAGR of 7.4% from 2026 to 2033.
  • In terms of segment, coronary stents was the largest revenue generating products in 2025.
  • Intravascular Imaging Catheters and Pressure Guidewires is the most lucrative products segment registering the fastest growth during the forecast period.
  • Country-wise, Germany is expected to register the highest CAGR from 2026 to 2033.


Europe data book summary

Market revenue in 2025USD 3,013.9 million
Market revenue in 2033USD 5,318.0 million
Growth rate7.4% (CAGR from 2026 to 2033)
Largest segmentCoronary stents
Fastest growing segmentIntravascular Imaging Catheters and Pressure Guidewires
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationCoronary Stents, PTCA Balloon Catheters, Intravascular Imaging Catheters and Pressure Guidewires, Accessory Devices
Key market players worldwideAbbott Laboratories, Medtronic PLC, Boston Scientific Corp, Koninklijke Philips NV, Cardinal Health Inc, Terumo Corp, Teleflex Inc, B. Braun, Biosensors, BIOTRONIK, Asahi Intecc Co Ltd, Cook Medical, Merit Medical Systems Inc, Haemonetics Corp, Vascular Solutions, Zeon Corp, Alvimedica, Meril Life, Medinol


Other key industry trends

  • In terms of revenue, Europe region accounted for 26.7% of the global interventional cardiology devices market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 4,837.3 million by 2033.

In Europe, the market for interventional cardiology devices is thriving due to ongoing innovations, regional approval of newer technologies, such as next-generation DES & BRS, and subsequent acceptance of these expensive technologies due to their benefits in revascularization treatments.

In addition, there are many ongoing initiatives for reduction of CVD burden in the region. For instance, in May 2023, the European Society of Cardiology collaborated with Europa Group and PCR to reduce the global prevalence of CVDs.

In May 2023, Canon Medical joined an advanced course in interventional cardiovascular medicine at the EuroPCR conference in France to learn about the latest dose-reduction devices & tools and cutting-edge technologies.

No credit card required*

Publish Date: Apr 15, 2026

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Interventional Cardiology Devices Market Companies

NameProfile# EmployeesHQWebsite
Abbott LaboratoriesView profile 114,000100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400www.abbottinvestor.com
Koninklijke Philips NVView profile 73,712Philips Center, Amstelplein 2, Amsterdam, Netherlands, 1096 BCwww.philips.com
Medtronic PLCView profile 95,000Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2www.medtronic.com
Boston Scientific CorpView profile 48,000300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234www.bostonscientific.com
Teleflex IncView profile 14,500550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087www.teleflex.com
Terumo CorpView profile 30,2072-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072www.terumo.com
Cardinal Health IncView profile 48,0007000 Cardinal Place, Dublin, OH, United States, 43017www.cardinalhealth.com
B. BraunView profile 10001+Chapeltown, Sheffield, United Kingdom, Europewww.bbraun.co.uk
Cook MedicalView profile 10001+Bloomington, Indiana, United States, North Americawww.cookmedical.com
BiosensorsView profile 1001-5000Singapore, Central Region, Singapore, Asiabiosensors.com

Europe Interventional Cardiology Devices Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Interventional Cardiology Devices Market Outlook will help companies and investors design strategic landscapes.


Coronary Stents was the largest segment with a revenue share of 50.91% in 2025.

Horizon Databook has segmented the Europe interventional cardiology devices market based on coronary stents, ptca balloon catheters, intravascular imaging catheters and pressure guidewires, accessory devices covering the revenue growth of each sub-segment from 2021 to 2033.




In Europe, the market for interventional cardiology devices is thriving due to ongoing innovations, regional approval of newer technologies, such as next-generation DES & BRS, and subsequent acceptance of these expensive technologies due to their benefits in revascularization treatments.

In addition, there are many ongoing initiatives for reduction of CVD burden in the region. For instance, in May 2023, the European Society of Cardiology collaborated with Europa Group and PCR to reduce the global prevalence of CVDs.

In May 2023, Canon Medical joined an advanced course in interventional cardiovascular medicine at the EuroPCR conference in France to learn about the latest dose-reduction devices & tools and cutting-edge technologies.

  • Europe Interventional Cardiology Devices Market Products Outlook (Revenue, USD Million , 2021-2033)
    • Coronary Stents
    • PTCA Balloon Catheters
    • Intravascular Imaging Catheters and Pressure Guidewires
    • Accessory Devices
  • Europe Interventional Cardiology Devices Market Procedures Outlook (Revenue, USD Million , 2021-2033)
    • Coronary Artery Disease (CAD)
    • Acute Myocardial Infarction (AMI)
    • Chronic Total Occlusion (CTO)
  • Europe Interventional Cardiology Devices Market End Use Outlook (Revenue, USD Million , 2021-2033)
    • Hospitals
    • Cath Labs
    • Ambulatory Surgical Centers (ASCs)
    • Specialty Cardiac Centers

Reasons to subscribe to Interventional Cardiology Devices Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Interventional Cardiology Devices Market Outlook databook

  • Our clientele includes a mix of Interventional Cardiology Devices Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Interventional Cardiology Devices Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Interventional Cardiology Devices Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Europe Interventional Cardiology Devices Market, 2021-2033 (US$M)

No Access Stack Chart

Europe interventional cardiology devices market statistics, by products, 2021-2033 (US$M)

No Access Pie Chart

Europe interventional cardiology devices market statistics, by country, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more